Market Closed -
Nyse
04:00:01 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
73.7
USD
|
+3.54%
|
|
+2.92%
|
+3.35%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
2,009
|
2,112
|
2,435
|
1,970
|
2,321
|
2,385
|
-
|
Enterprise Value (EV)
1 |
2,693
|
2,674
|
3,148
|
2,780
|
3,014
|
3,012
|
2,962
|
P/E ratio
|
15.2
x
|
18.9
x
|
15.1
x
|
16.3
x
|
27.6
x
|
12.6
x
|
10.9
x
|
Yield
|
0.35%
|
0.32%
|
0.27%
|
0.33%
|
0.35%
|
0.54%
|
0.54%
|
Capitalization / Revenue
|
1.12
x
|
1.32
x
|
1.31
x
|
0.93
x
|
1.07
x
|
1.03
x
|
1.01
x
|
EV / Revenue
|
1.5
x
|
1.68
x
|
1.69
x
|
1.31
x
|
1.39
x
|
1.3
x
|
1.25
x
|
EV / EBITDA
|
8.07
x
|
8.87
x
|
9.23
x
|
8.11
x
|
8.15
x
|
7.6
x
|
6.93
x
|
EV / FCF
|
15.5
x
|
15.3
x
|
21.5
x
|
118
x
|
21.5
x
|
19.5
x
|
16.4
x
|
FCF Yield
|
6.43%
|
6.53%
|
4.65%
|
0.85%
|
4.65%
|
5.12%
|
6.11%
|
Price to Book
|
1.42
x
|
1.5
x
|
1.58
x
|
1.26
x
|
1.4
x
|
-
|
-
|
Nbr of stocks (in thousands)
|
34,855
|
33,994
|
33,293
|
32,450
|
32,544
|
32,363
|
-
|
Reference price
2 |
57.63
|
62.12
|
73.15
|
60.72
|
71.31
|
73.70
|
73.70
|
Announcement Date
|
1/30/20
|
2/4/21
|
2/3/22
|
2/2/23
|
2/1/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
1,791
|
1,595
|
1,858
|
2,126
|
2,170
|
2,315
|
2,371
|
EBITDA
1 |
333.7
|
301.6
|
341
|
342.9
|
370
|
396.5
|
427.5
|
EBIT
1 |
235.3
|
213
|
240.7
|
252.5
|
69.2
|
303.6
|
335.5
|
Operating Margin
|
13.14%
|
13.36%
|
12.95%
|
11.88%
|
3.19%
|
13.12%
|
14.15%
|
Earnings before Tax (EBT)
1 |
157.3
|
138
|
202.3
|
156.7
|
107.7
|
246.4
|
275.4
|
Net income
1 |
132.7
|
112.4
|
164.4
|
122.2
|
84.1
|
187.3
|
211
|
Net margin
|
7.41%
|
7.05%
|
8.85%
|
5.75%
|
3.88%
|
8.09%
|
8.9%
|
EPS
2 |
3.780
|
3.290
|
4.860
|
3.730
|
2.580
|
5.845
|
6.745
|
Free Cash Flow
1 |
173.3
|
174.5
|
146.4
|
23.6
|
140.1
|
154.3
|
181
|
FCF margin
|
9.68%
|
10.94%
|
7.88%
|
1.11%
|
6.46%
|
6.67%
|
7.63%
|
FCF Conversion (EBITDA)
|
51.93%
|
57.86%
|
42.93%
|
6.88%
|
37.86%
|
38.91%
|
42.33%
|
FCF Conversion (Net income)
|
130.6%
|
155.25%
|
89.05%
|
19.31%
|
166.59%
|
82.38%
|
85.75%
|
Dividend per Share
2 |
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.2500
|
0.4000
|
0.4000
|
Announcement Date
|
1/30/20
|
2/4/21
|
2/3/22
|
2/2/23
|
2/1/24
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
473.2
|
476.9
|
519.1
|
557
|
541.9
|
507.6
|
546.1
|
551.5
|
547.8
|
524.5
|
534.5
|
581
|
588
|
601
|
582.1
|
EBITDA
1 |
87.1
|
83.6
|
91.6
|
96
|
90.1
|
65.3
|
85.7
|
92.7
|
101.9
|
89.7
|
100.6
|
102
|
105
|
98.35
|
102.5
|
EBIT
1 |
63.2
|
54.7
|
66.2
|
69.4
|
67.2
|
44
|
63
|
49.9
|
77
|
69.2
|
77.3
|
79.2
|
82.87
|
75.2
|
-
|
Operating Margin
|
13.36%
|
11.47%
|
12.75%
|
12.46%
|
12.4%
|
8.67%
|
11.54%
|
9.05%
|
14.06%
|
13.19%
|
14.46%
|
13.63%
|
14.09%
|
12.51%
|
-
|
Earnings before Tax (EBT)
1 |
50.5
|
50.1
|
56
|
56.3
|
17.1
|
27.4
|
47.7
|
34
|
-22.6
|
48.6
|
60.1
|
63.45
|
68.15
|
60.05
|
-
|
Net income
1 |
41.4
|
41.1
|
44.1
|
44.9
|
13.4
|
20
|
37
|
26.6
|
-19.2
|
39.8
|
46.7
|
48.25
|
51.85
|
45.65
|
-
|
Net margin
|
8.75%
|
8.62%
|
8.5%
|
8.06%
|
2.47%
|
3.94%
|
6.78%
|
4.82%
|
-3.5%
|
7.59%
|
8.74%
|
8.3%
|
8.82%
|
7.6%
|
-
|
EPS
2 |
1.220
|
1.230
|
1.330
|
1.360
|
0.4100
|
0.6200
|
1.140
|
0.8200
|
-0.5900
|
1.220
|
1.440
|
1.505
|
1.625
|
1.435
|
1.590
|
Dividend per Share
2 |
0.0500
|
0.0500
|
0.0500
|
0.0500
|
0.0500
|
0.0500
|
0.0500
|
0.0500
|
0.0500
|
0.1000
|
0.1000
|
0.1000
|
0.1000
|
0.1000
|
-
|
Announcement Date
|
11/4/21
|
2/3/22
|
4/28/22
|
7/28/22
|
10/27/22
|
2/2/23
|
4/27/23
|
7/27/23
|
10/26/23
|
2/1/24
|
4/25/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
684
|
562
|
713
|
810
|
693
|
627
|
577
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.051
x
|
1.865
x
|
2.09
x
|
2.361
x
|
1.873
x
|
1.58
x
|
1.349
x
|
Free Cash Flow
1 |
173
|
175
|
146
|
23.6
|
140
|
154
|
181
|
ROE (net income / shareholders' equity)
|
9.63%
|
7.85%
|
11.3%
|
10.3%
|
10.5%
|
10.9%
|
11.7%
|
ROA (Net income/ Total Assets)
|
4.28%
|
3.56%
|
5.16%
|
4.73%
|
5.04%
|
5.7%
|
6.3%
|
Assets
1 |
3,100
|
3,161
|
3,189
|
2,585
|
1,670
|
3,286
|
3,350
|
Book Value Per Share
|
40.60
|
41.50
|
46.40
|
48.30
|
50.80
|
-
|
-
|
Cash Flow per Share
|
6.790
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
65
|
66.1
|
86
|
82.3
|
93.5
|
94.2
|
92.3
|
Capex / Sales
|
3.63%
|
4.14%
|
4.63%
|
3.87%
|
4.31%
|
4.07%
|
3.89%
|
Announcement Date
|
1/30/20
|
2/4/21
|
2/3/22
|
2/2/23
|
2/1/24
|
-
|
-
|
Last Close Price
73.7
USD Average target price
89.5
USD Spread / Average Target +21.44% Consensus |
1st Jan change
|
Capi.
|
---|
| +3.35% | 2.39B | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|